"Peter J. Hotez and Maria Elena Bottazzi began development on the vaccine, known as CORBEVAX, in 2020 and currently are awaiting the final results of Phase Three clinical trials to determine its efficacy rate with respect to the Omicron COVID-19 variant.

In sharp contrast to the four dominant vaccines globally, CORBEVAX is protected by no patents or other intellectual property protection."

#RachelThrasher

https://www.bu.edu/gdp/2022/02/06/open-source-covid-19-vaccine-offers-potential-pathway-for-vaccinating-the-world/

#COVID #vaccines #CORBEVAX #DrugPatents

#TIL about Low Dose Naltrexone (LDN).

“LDN substantially reduces health care costs and improves treatment of a wide array of diseases. Unfortunately, because naltrexone has been without patent protection for many years, no pharmaceutical company will bear the expense of the large clinical trials necessary for FDA approval of LDN’s new special uses. It is now up to public institutions to seize the opportunity that LDN offers.”

#DrDavidGluck, MD

#health #MedicalResearch #DrugPatents

I have prescription allergy eye drops for severe allergies. They're still under patent protection.

They are over two dollars PER DROP.

I'd be so friggin screwed without Medicare right now. The drug company got to screw the taxpayers for that instead of me.

Also? They were less than a dollar a drop ten years ago.

Ridiculous.

#sickcare #healthcare #drugs #drugpatents #patents #pharma #bigpharma